glp 1 drugs in development Comparing Ozempic, Wegovy and Other GLP-1 Issue 42: GLP-1 RA Drug

doi: 10.1016/j.jdiacomp.2023.108631 14

High prevalence of atrophic body gastritis in patients with unexplained microcytic and macrocytic anemia

The bodys master antioxidant, glutathione, directly inactivates dangerous molecules directly responsible for aging, DNA damage, and oxidation or rusting of your cells

Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B 12 status

3.3 Mast cell degranulating (MCD) peptide Mast cell degranulating (MCD) Peptide, or peptide 401, is a BV polypeptide of 22 amino acids equivalent to apamin because it has two disulfide bridges (Rsinar et al., 2023)

Its primary mechanism is VEGF upregulation, the growth of new blood vessels that supply oxygen and nutrients to injured tissue, alongside nitric oxide pathway modulation and fibroblast stimulation in tendon and ligament tissue